Literature DB >> 29397323

Combination therapy with cytapheresis plus vedolizumab in a corticosteroid-dependent patient with ulcerative colitis and previous ANTI-TNF-α drug failure.

Esteban Sáez-González1, Mariam Aguas2, José M Huguet3, Pilar Nos4, Belén Beltrán2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29397323     DOI： 10.1016/j.dld.2018.01.124

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN： 1590-8658            Impact factor:   4.088


× No keyword cloud information.
  2 in total

1.  Refractory Ulcerative Colitis Improved by Scheduled Combination Therapy of Vedolizumab and Granulocyte and Monocyte Adsorptive Apheresis.

Authors:  Masanao Nakamura; Takeshi Yamamura; Keiko Maeda; Tsunaki Sawada; Yasuyuki Mizutani; Eri Ishikawa; Ayako Ohashi; Go Kajikawa; Kazuhiro Furukawa; Eizaburo Ohno; Takashi Honda; Hiroki Kawashima; Masatoshi Ishigami; Mitsuhiro Fujishiro
Journal:  Intern Med       Date:  2020-07-28       Impact factor: 1.271

Review 2.  Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy.

Authors:  Masahiro Iizuka; Takeshi Etou; Shiho Sagara
Journal:  World J Gastroenterol       Date:  2022-09-14       Impact factor: 5.374
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.